F. P. Marsh

670 total citations
31 papers, 470 citations indexed

About

F. P. Marsh is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, F. P. Marsh has authored 31 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Nephrology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in F. P. Marsh's work include Dialysis and Renal Disease Management (5 papers), Parathyroid Disorders and Treatments (4 papers) and Vitamin D Research Studies (3 papers). F. P. Marsh is often cited by papers focused on Dialysis and Renal Disease Management (5 papers), Parathyroid Disorders and Treatments (4 papers) and Vitamin D Research Studies (3 papers). F. P. Marsh collaborates with scholars based in United Kingdom, United States and Australia. F. P. Marsh's co-authors include John Cunningham, Martin Raftery, Michael Almond, H. Urich, Thomas W. Davies, R. H. Fox, F. J. Goodwin, W. Hately, J.T.C. Kwan and M. Chir and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Kidney International.

In The Last Decade

F. P. Marsh

29 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. P. Marsh United Kingdom 13 190 90 80 72 59 31 470
R. Morrison Hurley United States 15 221 1.2× 65 0.7× 111 1.4× 108 1.5× 86 1.5× 46 728
Rodo O. von Vigier Switzerland 16 197 1.0× 39 0.4× 108 1.4× 63 0.9× 99 1.7× 27 739
James A. Hasbargen United States 15 279 1.5× 57 0.6× 52 0.7× 108 1.5× 36 0.6× 30 646
Thomas J. Fuller United States 12 250 1.3× 63 0.7× 50 0.6× 148 2.1× 95 1.6× 22 656
Harry Stark Israel 11 190 1.0× 76 0.8× 182 2.3× 83 1.2× 68 1.2× 32 540
Maciej Drożdż Poland 10 114 0.6× 138 1.5× 81 1.0× 53 0.7× 17 0.3× 33 444
İsmail İşlek Türkiye 13 73 0.4× 65 0.7× 36 0.5× 54 0.8× 18 0.3× 34 389
Paolo Monardo Italy 13 230 1.2× 37 0.4× 56 0.7× 54 0.8× 26 0.4× 31 439
Johan Kofstad Norway 12 82 0.4× 74 0.8× 54 0.7× 259 3.6× 47 0.8× 27 714
Shobha Sahney United States 15 459 2.4× 33 0.4× 128 1.6× 155 2.2× 175 3.0× 30 735

Countries citing papers authored by F. P. Marsh

Since Specialization
Citations

This map shows the geographic impact of F. P. Marsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. P. Marsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. P. Marsh more than expected).

Fields of papers citing papers by F. P. Marsh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. P. Marsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. P. Marsh. The network helps show where F. P. Marsh may publish in the future.

Co-authorship network of co-authors of F. P. Marsh

This figure shows the co-authorship network connecting the top 25 collaborators of F. P. Marsh. A scholar is included among the top collaborators of F. P. Marsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. P. Marsh. F. P. Marsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grahame, Rodney, H. Anne Simmonds, M. B. McBride, & F. P. Marsh. (1998). How Should we Treat Tophaceous Gout in Patients with Allopurinol Hypersensitivity?. Advances in experimental medicine and biology. 431. 19–23. 8 indexed citations
2.
Kwan, J.T.C. & F. P. Marsh. (1996). Bilateral Nephrocalcinosis. New England Journal of Medicine. 334(17). 1105–1105. 1 indexed citations
3.
Wilkie, Martin, Stephen Evans, Martin Raftery, et al.. (1994). A double-blind, randomized, placebo-controlled study of nifedipine on early renal allograft function. Nephrology Dialysis Transplantation. 9(7). 800–804. 11 indexed citations
4.
Almond, Michael, et al.. (1994). Increased erythropoietin requirements in patients with failed renal transplants returning to a dialysis programme. Nephrology Dialysis Transplantation. 9(3). 270–273. 39 indexed citations
5.
Wilkie, Martin, et al.. (1993). Effect of nifedipine on renal haemodynamics and urinary protein excretion in stable renal transplant recipients.. PubMed. 25(1 Pt 1). 612–5. 4 indexed citations
6.
Almond, Michael, et al.. (1992). Diagnosis and management of urinary tract infection in adults.. BMJ. 305(6862). 1137–1141. 33 indexed citations
7.
Kwan, J.T.C., P. D’Arcy Hart, Martin Raftery, John Cunningham, & F. P. Marsh. (1991). Mycobacterial infection is an important infective complication in British Asian dialysis patients. Journal of Hospital Infection. 19(4). 249–255. 19 indexed citations
8.
Kwan, J.T.C., Jonathan Burdon, Martin Raftery, et al.. (1991). Carbamylated Haemoglobin, Urea Kinetic Modelling and Adequacy of Dialysis in Haemodialysis Patients. Nephrology Dialysis Transplantation. 6(1). 38–43. 31 indexed citations
9.
Moore, Richard H., G. A. Hitman, Nicholas T. Richards, et al.. (1990). HLA DQ region gene polymorphism associated with primary IgA nephropathy. Kidney International. 37(3). 991–995. 18 indexed citations
10.
Moore, Richard H., G. A. Hitman, Renato Alberto Sinico, et al.. (1990). Immunoglobulin heavy chain switch region gene polymorphisms in glomerulonephritis. Kidney International. 38(2). 332–336. 16 indexed citations
11.
Cunningham, John, et al.. (1989). Effect of Direction and Rate of Change of Calcium on Parathyroid Hormone Secretion in Uraemia. Nephrology Dialysis Transplantation. 4(5). 339–344. 13 indexed citations
12.
Altmann, Paul, et al.. (1987). Residual renal function in hemodialysis patients may protect against hyperaluminemia. Kidney International. 32(5). 710–713. 27 indexed citations
13.
Drew, Peter, et al.. (1985). The Effect of Cigarette Smoking and Previous Hypertension on the Survival of Patients Treated by Continuous Ambulatory Peritoneal Dialysis. Peritoneal Dialysis International. 5(1). 27–30. 6 indexed citations
14.
Goodwin, F. J., et al.. (1980). New system for single-needle dialysis.. BMJ. 281(6248). 1109–1110. 3 indexed citations
15.
Vandenburg, M. J., et al.. (1978). Prolonged treatment of high-renin hypertension with a converting enzyme inhibitor.. BMJ. 2(6141). 866–866. 1 indexed citations
16.
Brownjohn, A. M., F. J. Goodwin, W. Hately, et al.. (1977). 1-alpha-hydroxycholecalciferol for renal osteodystrophy.. BMJ. 2(6089). 721–723. 9 indexed citations
17.
Marsh, F. P., et al.. (1974). The relationship between urinary infection, cystoscopic appearance, and pathology of the bladder in man. Journal of Clinical Pathology. 27(4). 297–303. 14 indexed citations
18.
Marsh, F. P., et al.. (1972). THE RELATIONSHIP BETWEEN BACTERIAL CULTURES OF THE VAGINAL INTROITUS AND URINARY INFECTION. British Journal of Urology. 44(3). 368–375. 30 indexed citations
19.
Dathan, J R, et al.. (1970). One Year's Experience in a Ministry of Health Dialysis Centre. BMJ. 2(5701). 102–105. 6 indexed citations
20.
Fox, R. H., Thomas W. Davies, F. P. Marsh, & H. Urich. (1970). HYPOTHERMIA IN A YOUNG MAN WITH AN ANTERIOR HYPOTHALAMIC LESION. The Lancet. 296(7665). 185–188. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026